Javier Sastre

10.3k total citations · 3 hit papers
177 papers, 6.7k citations indexed

About

Javier Sastre is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Javier Sastre has authored 177 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 142 papers in Oncology, 58 papers in Pulmonary and Respiratory Medicine and 41 papers in Surgery. Recurrent topics in Javier Sastre's work include Colorectal Cancer Treatments and Studies (92 papers), Gastric Cancer Management and Outcomes (40 papers) and Cancer Treatment and Pharmacology (40 papers). Javier Sastre is often cited by papers focused on Colorectal Cancer Treatments and Studies (92 papers), Gastric Cancer Management and Outcomes (40 papers) and Cancer Treatment and Pharmacology (40 papers). Javier Sastre collaborates with scholars based in Spain, France and United States. Javier Sastre's co-authors include Eduardo Díaz‐Rubio, Josep Tabernero, Enrique Aranda, José Á. García-Sáenz, Eric Van Cutsem, Thierry André, Pia Österlund, Irmarie Reyes‐Rivera, Fernando Rivera and Roger von Moos and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Javier Sastre

172 papers receiving 6.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial

2012 829 citations Javier Sastre, José María Viéitez et al. profile →
Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial

2015 634 citations Javier Sastre et al. profile →
nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial

2015 504 citations Javier Sastre, Josep Tabernero et al. profile →

Peers

Countries citing papers authored by Javier Sastre

Since Specialization

Citations

This map shows the geographic impact of Javier Sastre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Javier Sastre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Javier Sastre more than expected).

Fields of papers citing papers by Javier Sastre

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Javier Sastre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Javier Sastre. The network helps show where Javier Sastre may publish in the future.

Co-authorship network of co-authors of Javier Sastre

This figure shows the co-authorship network connecting the top 25 collaborators of Javier Sastre. A scholar is included among the top collaborators of Javier Sastre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Javier Sastre. Javier Sastre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	SEOM-GEMCAD-TTD clinical guidelines for the management of hepatocarcinoma patients (2023) 2024 ·Clinical & Translational Oncology ·Carlos López, Mariona Calvo, Juan Carlos Cámara, Beatriz García-Paredes, Carlos Gómez-Martín, (unknown), Roberto Pazo-Cid, Javier Sastre, Ricardo Yayá, Jaime Feliú	2
2	Molecular Classification of Colorectal Cancer by microRNA Profiling: Correlation with the Consensus Molecular Subtypes (CMS) and Validation of miR-30b Targets 2022 ·Cancers ·(unknown), (unknown), (unknown), Daniel Tabas‐Madrid, (unknown), María Jesús Fernández‐Aceñero, Javier Sastre, Alberto Pascual-Montano, Santos Mañes, Eduardo Díaz‐Rubio, Beatriz Pérez‐Villamil	6
3	SEOM-GEMCAD-TTD clinical guidelines for localized rectal cancer (2021) 2022 ·Clinical & Translational Oncology ·Jaume Capdevila, (unknown), (unknown), David Páez, Carles Pericay, María José Safont, Noelia Tarazona, Ruth Vera, Joana Vidal, Javier Sastre	9
4	Upfront primary tumour resection and survival in synchronous metastatic colorectal cancer according to primary tumour location and RAS status: Pooled analysis of the Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) 2021 ·European Journal of Surgical Oncology ·Manuel Benavides, Auxiliadora Gómez‐España, Pilar García‐Alfonso, (unknown), José María Viéitez, Fernando Rivera, María José Safont, Albert Abad, Javier Sastre, Manuel Valladares‐Ayerbes, Alfredo Carrato, Encarnación González‐Flores, Luis Robles, Antonieta Salud, Vicente Alonso-Orduña, Clara Montagut, Elena Asensio, Eduardo Díaz‐Rubio, Enrique Aranda	3
5	FOLFOXIRI plus bevacizumab versus FOLFOX plus bevacizumab for patients with metastatic colorectal cancer and ≥3 circulating tumour cells: the randomised phase III VISNÚ-1 trial 2020 ·ESMO Open ·Enrique Aranda, José María Viéitez, Auxiliadora Gómez‐España, (unknown), Antonieta Salud, (unknown), Pilar García‐Alfonso, Fernando Rivera, (unknown), (unknown), Encarnación González‐Flores, Mercedes Salgado Fernández, Carmen Guillén‐Ponce, Rocio García‐Carbonero, María José Safont, Adelaida La Casta, Beatriz García-Paredes, Rafael López‐López, Javier Sastre, Eduardo Díaz‐Rubio	39
6	microRNA(miR) subtypes correlates with colorectal cancer(CRC) molecular subtypes: Validation of miR-30b interaction with genes up-regulated in the high-stroma subtype 2017 ·Annals of Oncology ·Beatriz Pérez‐Villamil, (unknown), (unknown), (unknown), Javier Sastre, Santos Mañes, Eduardo Díaz‐Rubio	1
7	Diagnóstico y tratamiento del carcinoma hepatocelular. Actualización del documento de consenso de la AEEH, SEOM, SERAM, SERVEI y SETH 2016 ·Medicina Clínica ·Alejandro Forner, María Reig, Marı́a Varela, Marta Burrel, Jaime Feliú, Javier Briceño, Javier Sastre, Luis Martí‐Bonmatí, Josep M. Llovet, José Ignacio Bilbao, Bruno Sangro, Fernando Pardo, Carmen Ayuso, Concepció Brú, Josep Tabernero, Jordi Bruix	30
8	Analysis of Molecular Alterations for Predicting Clinical Benefit to Cetuximab Plus Chemotherapy in First-Line Metastatic Colorectal Cancer (MCRC) 2014 ·Annals of Oncology ·Javier Sastre, Patricia Llovet, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Cristina Grávalos, (unknown), (unknown), (unknown), Trinidad Caldés, (unknown)	1
9	Prognostic Value of the Combination of Circulating Tumor Cells Plus KRAS in Patients With Metastatic Colorectal Cancer Treated With Chemotherapy Plus Bevacizumab 2013 ·Clinical Colorectal Cancer ·Javier Sastre, Marta Vidaurreta, (unknown), Fernando Rivera, Bartomeu Massutí, (unknown), Albert Abad, Manuel Gallén, Manuel Benavides, Enrique Aranda, Eduardo Díaz‐Rubio	30
10	Sorafenib for non-selected patient population with advanced hepatocellular carcinoma: efficacy and safety data according to liver function 2012 ·Clinical & Translational Oncology ·Jon Zugazagoitia, Aránzazu Manzano, Javier Sastre, José M. Ladero, Javier Puente, Eduardo Díaz‐Rubio	13
11	Influence of KRAS p.G13D Mutation in Patients With Metastatic Colorectal Cancer Treated With Cetuximab 2012 ·Clinical Colorectal Cancer ·Pablo Gajate, Javier Sastre, Inmaculada Bando, Teresa Alonso, (unknown), Julián Sanz‐Ortega, Trinidad Caldés, Eduardo Díaz‐Rubio	28
12	Role of Kras Status in Patients with Metastatic Colorectal Cancer Receiving First-Line Chemotherapy plus Bevacizumab: A TTD Group Cooperative Study 2012 ·PLoS ONE ·Eduardo Díaz‐Rubio, Auxiliadora Gómez‐España, Bartomeu Massutí, Javier Sastre, Margarita Reboredo, José Luís Zamora Manzano, Fernando Rivera, (unknown), Clara Montagut, Encarnación González‐Flores, Manuel Benavides, Eugenio Marcuello, Andrés Cervantes, Purificación Martínez de Prado, Carlos Fernández-Martos, A. Arriví, Inmaculada Bando, (unknown), (unknown)	35
13	Irinotecan-Cetuximab-Bevacizumab as a Salvage Treatment in Heavily Pretreated Metastatic Colorectal Cancer Patients: A Retrospective Observational Study 2011 ·Chemotherapy ·Jaime Feliú Batlle, Elena Cuadrado‐Payán, (unknown), Trinidad Caldés, Cristóbal Belda-Iniesta, Javier Sastre, Jorge Barriuso, (unknown), Eduardo Díaz‐Rubio, Manuel González-Barón	6
14	Practical prognostic index for patients with metastatic recurrent breast cancer: retrospective analysis of 2,322 patients from the GEICAM Spanish El Alamo Register 2010 ·Breast Cancer Research and Treatment ·Javier Puente, Sara López‐Tarruella, Amparo Ruı́z, Aňa Lluch, (unknown), Emilio Alba, Juan de la Haba-Rodríguez, Manuel Ramos, Luis Cirera, Antonio Antón, Antonio Llombart‐Cussac, Arrate Plazaola, António Fernández, Javier Sastre, Eduardo Díaz‐Rubio, Miguel Martín	36
15	Diagnóstico y tratamiento del carcinoma hepatocelular 2009 ·Medicina Clínica ·Alejandro Forner, Carmen Ayuso, María Isabel Real, Javier Sastre, R Robles, Bruno Sangro, Marı́a Varela, Manuel de la Mata, Marı́a Buti, Luis Martí‐Bonmatí, Concepció Brú, Josep Tabernero, Josep M. Llovet, Jordi Bruix	54
16	Treatment of the elderly colorectal cancer patient: SIOG expert recommendations 2008 ·Annals of Oncology ·D. Papamichael, Riccardo A. Audisio, (unknown), Bengt Glimelius, Javier Sastre, Emmanuel Mitry, E. Van Cutsem, Margot Gosney, C.-H. Köhne, Matti Aapro	134
17	Circulating tumor cells in colorectal cancer: correlation with clinical and pathological variables 2008 ·Annals of Oncology ·Javier Sastre, M.L. Maestro, Javier Puente, S. Veganzones, Rosario Alfonso, S. Rafael, José Á. García-Sáenz, Marta Vidaurreta, Miguel Martín, Manuel Arroyo, María Teresa Sanz Casla, Eduardo Díaz‐Rubio	185
18	Genetic variability in CYP3A4 and CYP3A5in primary liver, gastric and colorectal cancer patients 2007 ·BMC Cancer ·Guillermo Gervasini, Elena Garcı́a-Martı́n, José M. Ladero, (unknown), Javier Sastre, Carmen Martínez, (unknown), Manuel Díaz‐Rubio, José A. G. Agúndez	20
19	Cetuximab plus oxaliplatin/5-fluorouracil (5-FU)/folinic acid (FA) (FOLFOX-4) for the epidermal growth factor receptor (EGFR)expressing metastatic colorectal cancer (mCRC) in the first-line setting: a phase II study 2005 ·European Journal of Cancer Supplements ·Andrés Cervantes, Yves Humblet, (unknown), (unknown), Javier Sastre, Thierry André, Jean–Luc Van Laethem, Angela Zubel, (unknown), Aimery de Gramont	13
20	Two Consecutive Phase II Trials of Biweekly Oxaliplatin plus Weekly 48-Hour Continuous Infusion of Nonmodulated High-Dose 5-Fluorouracil as First-Line Treatment for Advanced Colorectal Cancer 2005 ·Clinical Colorectal Cancer ·Albert Abad, Alfredo Carrato, Matilde Navarro, Javier Sastre, Andrés Cervantes, Antonio Antón, (unknown), Eugenio Marcuello, (unknown), Enrique Aranda, José Luís Zamora Manzano, (unknown), Eduardo Díaz‐Rubio	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact